After almost 10 years at the UA College of Pharmacy and the long road to getting the program in Phoenix started and expanded, Philip Schneider, MS, FASHP, is retiring from the College of Pharmacy effective Dec. 31, 2017. Mr. Schneider is a professor and associate dean for academic and professional affairs for the College of Pharmacy at the Phoenix Biomedical Campus. In this position, he provides oversight, development and administration of educational initiatives including teaching, service and scholarship activities.
“Phil has done an exceptional job developing the College at the Phoenix Biomedical Campus,” said Rick Schnellmann, professor and dean. “His oversight helped establish and grow our PharmD program in Phoenix, beginning with 3 in 2014 and 39 this year, ensuring that students received a quality education and experience. We are grateful for his service.”
Prior to these positions, he held positions at the Ohio State University including most recently Clinical Professor and Director of the Latiolais Leadership Program, an interprofessional program to advance leadership in pharmacy to improve the medication-use system and reduce adverse drug events.
During his 47 years of professional and academic service, he has published more than 225 articles and abstracts in professional and scientific journals, 57 book chapters, edited 16 books and monographs and given more than 637 contributed or invited presentations in 29 countries and the US. He is a past-president of the American Society of Health-System Pharmacist and member of the ASHP Visiting Leaders Program faculty, and past-president of the American Society for Parenteral and Enteral Nutrition, having served for ten years as the first Editor-in-Chief of Nutrition in Clinical Practice, one of its two official publications.
Active in international pharmacy, he has served Chairman of the Board of Pharmaceutical Practice of the International Pharmaceutical Federation, Secretary and newsletter editor of the Hospital Pharmacy Section, chairman of the Congress Planning Committee, chairman of the Planning Committee for the Global Conference on Pharmacy and Pharmaceutical Sciences and is now a Vice President of FIP.
Mr. Schneider’s scholarly interest is factors that affect the use of medications. The domains that he has studied include the impact of different models of care delivery, including an interprofessional approach, regulatory changes, drug distribution models, the use of medication-related technologies, and how drugs are packaged.
Upon sharing his retirement, Mr. Schneider mentioned this in his correspondence.
“Although it has been a challenge requiring a lot of patience and perseverance, the College can be proud of this program, and the students, faculty and staff on the Phoenix Biomedical Campus. It was my privilege to be part of making it happen.”
Thank you, Mr. Schneider, for your leadership and service to the College!